Modulating the immune protein PD-L1 restores microglial function and alleviates abnormal neuronal hyperactivity ...

For decades, research into Alzheimer's disease has made painfully little progress. More than 7 million Americans are living ...

Together with Worldwide Clinical Trials, Alzinova has completed the Phase II study kick-off and commenced the operational start-up phase. Approximately 120 participants with early Alzheimer’s disease ...

Three University of Waterloo students are conducting research in Dr. Zoya Leonenko's lab, searching for answers to ...

In Living Better with Ambetter, Jennifer Walker, Executive Director for Alabama and Mississippi with the Alzheimer’s Association, visited Studio 3 to discuss why this year marks a pivotal, hopeful ...

Alzheimer’s drug development remains fraught with failure, but antioxidant-focused strategies show the most promise compared to anti-amyloid, anti-tau, or anti-inflammatory approaches. Novo Nordisk ...

Alzheimer’s disease can progress for years without obvious symptoms, while researchers continue searching for new ways to ...

Navigating Alzheimer’s Agitation survey finds that Alzheimer’s disease agitation is often only recognized after daily life is ...

Cognition refers to the mind’s ability to remember, pay attention, plan, and execute tasks. Treatments aimed at improving cognition may also improve a person’s performance of daily function—eating, ...

Researchers believe hearing loss may make the brain work harder. At the cost of thinking and memory, it can also lead people ...

Professor Minah Suh of the Department of Biomedical Engineering at Sungkyunkwan University, in collaboration with the ...

Treatment is getting better — fast. Here's how we can all benefit.